Onset of Microscopic Polyangiitis in Binephrectomied Patient on Chronic Hemodialysis-Case Report

Aleksandar Jankovic1, Vesna Maslarevic-Radovic1, Petar Djuric1

  • 1Clinical Department for Nephrology with Dialysis, University Medical Center Zvezdara , Belgrade , Serbia.

Abstract

Insights

Microscopic polyangiitis (MPA) can develop in patients undergoing chronic hemodialysis (HD). Early diagnosis and standard immunosuppression led to sustained remission in a patient with newly diagnosed MPA after 4 years on HD.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) is a pulmonary-renal syndrome often linked to ANCA positivity.
  • De novo MPA development in patients on chronic hemodialysis (HD) is rare and previously undescribed.
  • MPA diagnosis typically involves ANCA positivity (50-75%) and inflammation markers.

Purpose of the Study:

  • To report a novel case of de novo microscopic polyangiitis in a patient on chronic hemodialysis.
  • To highlight the diagnostic challenges and successful management of MPA in this specific patient population.
  • To emphasize the possibility of immune-mediated disease onset even after initiating renal replacement therapy.

Main Methods:

  • Case report of a patient on chronic HD who developed MPO-ANCA-associated MPA.
  • Diagnosis confirmed through clinical presentation (lung and musculoskeletal involvement) and MPO-ANCA positivity, without renal biopsy.
  • Patient managed with standard immunosuppression therapy.

Main Results:

  • The patient developed MPO-ANCA-associated MPA after 4 years of regular HD.
  • Diagnosis was established by excluding other causes of MPO-ANCA positivity.
  • The patient achieved and maintained remission for 27 months following immunosuppressive treatment.

Conclusions:

  • Immune-mediated diseases like MPA can manifest after the initiation of renal replacement therapy.
  • The onset of MPA in HD patients presents diagnostic challenges.
  • Early diagnosis and conventional immunosuppressive therapy are effective for achieving remission in MPA.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
419
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.5K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
835
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K